Diligent Pharma has filed a notice of an exempt offering of securities to raise $9,250,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Diligent Pharma is raising $9,250,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Patricia Leuchten played a key role in…